WASHINGTON, October 25, 2007— King & Spalding, a leading international law firm, will provide significant substantive support to one of the pharmaceutical industry's premier fraud & abuse compliance conferences, as three attorneys in the firm's FDA/ Healthcare practice will present at the 8th Annual Pharmaceutical Regulatory and Compliance Congress. The conference will take place in Washington, D.C. November 7 - 9, 2007. The firm will also serve as a bronze-level sponsor of this significant industry event.
Partners John Bentivoglio and Kelly N. Reeves and counsel John Shakow will present three separate panels on the second day of the conference. Bentivoglio -- co-leader of King & Spalding's FDA/ Healthcare group and a member of the planning committee for the Congress -- will be speaking on compliance with state marketing, ethics and disclosure laws. Reeves will be describing how pharmaceutical manufacturers can conduct comprehensive and effective clinical research compliance assessments. Shakow will be addressing third party contracting and compliance in light of recent regulatory activity in pharmaceutical pricing.
The Pharmaceutical Regulatory and Compliance Congress was established 1999 in response to the heightened need for corporate compliance programs, increased government scrutiny and new regulations being imposed upon the pharmaceutical industry. Pharmaceutical professionals looking for a comprehensive understanding of the current and future compliance laws and regulations and enforcement initiatives affecting the pharmaceutical industry should plan to attend.
For additional information about the 8th Annual Pharmaceutical Regulatory and Compliance Congress, visit www.pharmacongress.com.
King & Spalding's FDA/Healthcare Practice represents pharmaceutical, medical device, biotechnology and other healthcare technology companies, as well as food manufacturers, in a wide range of regulatory, compliance, policy, and litigation matters. Thirty-three (33) lawyers and non-lawyer professionals in our Washington, DC office provide sophisticated counseling and advice to more than 150 drug and device manufacturers and others in the healthcare technology sector, including nine of the 25 largest pharmaceutical manufacturers and 18 of the 25 largest device manufacturers.
About King & Spalding
King & Spalding is an international law firm with more than 800 lawyers in Atlanta, Charlotte, Dubai, Frankfurt, Houston, London, New York, Riyadh (affiliated office) and Washington, D.C. The firm represents half of the Fortune 100 and in a Corporate Counsel survey in September 2007 was among the top firms representing Fortune 250 companies. For additional information, visit www.kslaw.com.
